Press Tag: Basking Biosciences

Categories
Basking Biosciences Doses First Patients in Part B of Phase 2 Stroke Trial, Unlocks $27.5 Million Financing Tranche, and Appoints Julia C. Owens, Ph.D. as Chief Executive Officer
Company News, Funding News
Basking Biosciences Doses First Patients in Part B of Phase 2 Stroke Trial, Unlocks $27.5 Million Financing Tranche, and Appoints Julia C. Owens, Ph.D. as Chief Executive Officer
Ohio State-Duke spinoff Basking Biosciences raises $55M to test stroke treatment
Company News
Ohio State-Duke spinoff Basking Biosciences raises $55M to test stroke treatment
Basking Biosciences closes US$55 million financing to further reversible stroke thrombolytic
Company News
Basking Biosciences closes US$55 million financing to further reversible stroke thrombolytic
Basking Biosciences Closes $5.4M Seed Financing
Company News
Basking Biosciences Closes $5.4M Seed Financing